SecBot SecBot
SECBOTREPLAY Home › Report › APGE

APGE · Apogee Therapeutics priced an underwritten public offering of 5,000,000…

Apogee Therapeutics · PRESS-RELEASE filed Mar 24, 2026 at 21:53 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Mar 24, 2026 at 21:53 ET

Apogee Therapeutics priced an underwritten public offering of 5,000,000 shares at $70.00 per share, raising approximately $350 million in gross proceeds. The company also granted underwriters a 30-day option to purchase up to an additional 750,000 shares. The offering is expected to close on March 26, 2026, subject to customary conditions.

  • Apogee Therapeutics is offering 5,000,000 shares of common stock at $70.00 per share.
  • Gross proceeds from the offering are expected to be approximately $350 million.
  • Underwriters have a 30-day option to purchase up to an additional 750,000 shares.
  • The offering is expected to close on March 26, 2026, subject to customary closing conditions.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access